Data protection Impressum

Additive Manufacturing

Geneva-based Syrhatech has raised CHF 4.5 million to expand its R&D and manufacturing of injectable hyaluronic acid-based medical devices to support growing demand in dermatology, orthopedics, and ophthalmology.

Syrhatech raises CHF 4.5 million to innovate in hyaluronic acid medical devices

27 May 2025

For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation with economic growth.

The remarkable chemical-pharmaceutical industry in the canton of Valais

CDMOs play a crucial role in the pharmaceutical sector, serving as key partners in the drug development and production process.

Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings

16 October 2023

CERN establishes task force to fight COVID-19

14 April 2020